UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms involved in follistatin‐induced hypertrophy and increased insulin action in skeletal muscle

Journal of cachexia, sarcopenia and muscle, 2019-12, Vol.10 (6), p.1241-1257

2019

Volltextzugriff (PDF)

The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis-Dysregulation by the Liver

Journal of clinical medicine, 2021-01, Vol.10 (3), p.390

2021

Volltextzugriff (PDF)

Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass

Physiological reports, 2022-01, Vol.10 (2), p.e15157-n/a

2022

Volltextzugriff (PDF)

New Lessons from the gut: Studies of the role of gut peptides in weight loss and diabetes resolution after gastric bypass and sleeve gastrectomy

Peptides (New York, N.Y. : 1980), 2024-06, Vol.176, p.171199-171199, Article 171199

2024

Volltextzugriff (PDF)

Dietary Regulation of Hepatic Triacylglycerol Content-the Role of Eucaloric Carbohydrate Restriction with Fat or Protein Replacement

Advances in nutrition (Bethesda, Md.), 2023-11, Vol.14 (6), p.1359-1373

2023

Volltextzugriff (PDF)

Mechanisms of action of a carbohydrate-reduced, high-protein diet in reducing the risk of postprandial hypoglycemia after Roux-en-Y gastric bypass surgery

The American journal of clinical nutrition, 2019-08, Vol.110 (2), p.296-304

2019

Volltextzugriff (PDF)

Early effects of Roux-en-Y gastric bypass on dietary fatty acid absorption and metabolism in people with obesity and normal glucose tolerance

International Journal of Obesity, 2022-07, Vol.46 (7), p.1359-1365

2022

Volltextzugriff (PDF)

In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans

American journal of physiology. Regulatory, integrative and comparative physiology, 2016-05, Vol.310 (9), p.R866-R874

2016

Volltextzugriff (PDF)

The impact of short-term eucaloric low- and high-carbohydrate diets on liver triacylglycerol content in males with overweight and obesity: a randomized crossover study

The American journal of clinical nutrition, 2024-08, Vol.120 (2), p.283-293

2024

Volltextzugriff (PDF)

Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake

International Journal of Obesity, 2023-11, Vol.47 (11), p.1143-1151

2023

Volltextzugriff (PDF)

GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment

Pharmacological research, 2022-02, Vol.176, p.106058, Article 106058

2022

Volltextzugriff (PDF)

Effects of Roux-en-Y gastric bypass on circulating follistatin, activin A, and peripheral ActRIIB signaling in humans with obesity and type 2 diabetes

International Journal of Obesity, 2021-02, Vol.45 (2), p.316-325

2021

Volltextzugriff (PDF)

Pros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes

Expert review of endocrinology & metabolism, 2019-07, Vol.14 (4), p.243-257

2019

Volltextzugriff (PDF)

Updates in weight loss surgery and gastrointestinal peptides

Current opinion in endocrinology, diabetes, and obesity, 2015-02, Vol.22 (1), p.21-28

2015

Volltextzugriff (PDF)

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

Danish medical journal, 2015-04, Vol.62 (4), p.B5057

Bojsen-Møller, Kirstine Nyvold

2015

Volltextzugriff (PDF)

Effect of ghrelin on glucose tolerance, gut hormones, appetite, and food intake after sleeve gastrectomy

American journal of physiology: endocrinology and metabolism, 2024-09, Vol.327 (3), p.E396-E410

2024

Volltextzugriff (PDF)

In vivo and in vitro degradation of peptide YY 3–36 to inactive peptide YY 3–34 in humans

American journal of physiology. Regulatory, integrative and comparative physiology, 2016-05, Vol.310 (9), p.R866-R874

2016

Volltextzugriff (PDF)

In vivo and in vitro degradation of peptide YY^sub 3-36^ to inactive peptide YY^sub 3-34^ in humans

American journal of physiology. Regulatory, integrative and comparative physiology, 2016-05, Vol.310 (9), p.R866

2016

Volltextzugriff (PDF)

Medical therapy versus bariatric surgery of obese patients with Type 2 diabetes

Ugeskrift for læger, 2016-10, Vol.178 (44)

2016

Volltextzugriff (PDF)

Emerging drugs for the treatment of obesity

Expert opinion on emerging drugs, 2017-01, Vol.22 (1), p.87-99

2017

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(20)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Mechanisms involved in follistatin‐induced hypertrophy and increased insulin action in skeletal muscle

The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis-Dysregulation by the Liver

Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass

New Lessons from the gut: Studies of the role of gut peptides in weight loss and diabetes resolution after gastric bypass and sleeve gastrectomy

Dietary Regulation of Hepatic Triacylglycerol Content-the Role of Eucaloric Carbohydrate Restriction with Fat or Protein Replacement

Mechanisms of action of a carbohydrate-reduced, high-protein diet in reducing the risk of postprandial hypoglycemia after Roux-en-Y gastric bypass surgery

Early effects of Roux-en-Y gastric bypass on dietary fatty acid absorption and metabolism in people with obesity and normal glucose tolerance

In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans

The impact of short-term eucaloric low- and high-carbohydrate diets on liver triacylglycerol content in males with overweight and obesity: a randomized crossover study

Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake

GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment

Effects of Roux-en-Y gastric bypass on circulating follistatin, activin A, and peripheral ActRIIB signaling in humans with obesity and type 2 diabetes

Pros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes

Updates in weight loss surgery and gastrointestinal peptides

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

Effect of ghrelin on glucose tolerance, gut hormones, appetite, and food intake after sleeve gastrectomy

In vivo and in vitro degradation of peptide YY 3–36 to inactive peptide YY 3–34 in humans

In vivo and in vitro degradation of peptide YY^sub 3-36^ to inactive peptide YY^sub 3-34^ in humans

Medical therapy versus bariatric surgery of obese patients with Type 2 diabetes

Emerging drugs for the treatment of obesity

Suchergebnisse filtern